Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application

Despite the discovery that the human immunodeficiency virus 1 (HIV-1) is the pathogen of acquired immunodeficiency syndrome (AIDS) in 1983, there is still no effective anti-HIV-1 vaccine. The major obstacle to the development of HIV-1 vaccine is the extreme diversity of viral genome sequences. Nonet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Chengchao, Patel, Darshit, Ma, Yunjing, Mann, Jamie F. S., Wu, Jianjun, Gao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329590/
https://www.ncbi.nlm.nih.gov/pubmed/34354709
http://dx.doi.org/10.3389/fimmu.2021.697683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329590/
https://www.ncbi.nlm.nih.gov/pubmed/34354709
http://dx.doi.org/10.3389/fimmu.2021.697683

Ejemplares similares